News & Events July 9, 2023 Wockhardt charting a recovery riding on a promising new antibioticJune 10, 2023 Engaging the pharmaceutical industry in joint efforts to tackle antimicrobial resistanceFebruary 21, 2023 A game-changer: India’s under-trial drug shows promise against hospital superbugsFebruary 12, 2023 Under-trial antibiotic use saves minor thalassemia patient’s lifeNovember 13, 2022 Desi superbug antibiotic under trial saves Nepalese August 16, 2022 Wockhardt initiates phase-III clinical study of new antibiotic candidateMarch 16, 2022 National Institutes of Health (NIH), USA to conduct human Phase 1 trial of Wockhardt’s novel once-a-day MDR Gram-negative antibiotic WCK 6777August 26, 2021 Wockhardt and Jemincare partner for novel respiratory antibiotic NafithromycinJanuary 16, 2021 India’s first new discovery antibiotics from Wockhardt granted Indian regulatory approval
